Jakavi 15mg Tablet
Images are for reference. Actual packaging may vary.
Strip of 10 tablets • TabletPrescription requiredSchedule H
Jakavi 15mg Tablet
Ruxolitinib (15mg)
₹50340.00
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Ruxolitinib 15 mg
How It Works
Ruxolitinib inhibits Janus kinases (JAK1 and JAK2), reducing signaling pathways that promote cell growth and survival in myeloproliferative disorders.
Medicine Strength
15 mg
Uses & Benefits
Medical applications
Infection
Jakavi 15mg Tablet contains Ruxolitinib, a potent Janus kinase (JAK) inhibitor indicated for the treatment of myelofibrosis, polycythemia vera, and other related myeloproliferative disorders. Ruxolitinib selectively inhibits JAK1 and JAK2 enzymes, which play a critical role in the signaling pathways involved in hematopoiesis and immune function. By modulating these pathways, Jakavi helps reduce splenomegaly, alleviate disease-related symptoms such as fatigue, night sweats, and pruritus, and improve overall quality of life in affected patients.
Read full descriptionShow less
The 15mg dosage is typically administered orally twice daily, with dose adjustments based on clinical response and hematologic parameters. Common adverse effects include anemia, thrombocytopenia, and increased susceptibility to infections; therefore, regular monitoring of blood counts and liver function tests is recommended during therapy. Jakavi is contraindicated in patients with known hypersensitivity to Ruxolitinib or its excipients and should be used cautiously in individuals with active infections or hepatic impairment.
This medication should be prescribed and managed by healthcare professionals experienced in the treatment of myeloproliferative neoplasms to ensure optimal therapeutic outcomes and minimize potential risks. Patient education regarding adherence and monitoring is essential for safe and effective use of Jakavi 15mg Tablet.
Dosage & How to Use
Pyrrolo[2,3-d]pyrimidines Derivative
Safety Advice
Important precautions
Side effects
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Safety Advice
Alcohol
Jakavi 15mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Jakavi 15mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Jakavi 15mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Jakavi 15mg Tablet may be needed. Please consult your doctor. Use of Jakavi 15mg Tablet is not advised in patients with moderate to severe kidney disease.
Exercise Caution
Breastfeeding
Jakavi 15mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Jakavi 15mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Jakavi 15mg Tablet may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Jakavi 15mg Tablet
